Suppressive regulation of KSHV RTA with O-GlcNAcylation

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Ko, Ying Chieh ^a   Tsai, Wan Hua ^a   Wang, Pei Wen ^a   Wu, I Lin ^b   Lin, Shu Yu ^b   Chen, Yu Lian ^a   Chen, Jen Yang ^a   Lin, Su Fang ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

K RTA; KSHV; O GlcNAcylation; PARP1; Polycomb group (PcG) complex

Indexed keywords

ALANINE; LUCIFERASE; N ACETYLGLUCOSAMINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; O LINKED N ACETYLGLUCOSAMINE; O LINKED N ACETYLGLUCOSAMINE TRANSFERASE; POLYMER; REGULATOR PROTEIN; REPLICATION AND TRANSCRIPTION ACTIVATOR PROTEIN; SERINE; SHORT HAIRPIN RNA; THREONINE; TRANSFERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; FLAG PEPTIDE; IMMEDIATE EARLY PROTEIN; N ACETYLGLUCOSAMINYLTRANSFERASE; O GLCNAC TRANSFERASE; O-GLCNAC TRANSFERASE; PARP1 PROTEIN, HUMAN; PEPTIDE; RTA PROTEIN, HUMAN HERPESVIRUS 8; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINOACYLATION; ARTICLE; ASSAY; CELL METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PROCESSING; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY; TRANSCRIPTION INITIATION; TRANSLATION REGULATION; VIRUS MUTANT; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WESTERN BLOTTING; ACYLATION; CELL STRAIN HEK293; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; MASS FRAGMENTOGRAPHY; METABOLISM;

HUMAN HERPESVIRUS 8;

ACYLATION; ALANINE; AMINO ACID SUBSTITUTION; BLOTTING, WESTERN; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOPRECIPITATION; N-ACETYLGLUCOSAMINYLTRANSFERASES; PEPTIDES; POLY(ADP-RIBOSE) POLYMERASES; RNA, SMALL INTERFERING; TANDEM MASS SPECTROMETRY; THREONINE; TRANS-ACTIVATORS;

EID: 84856481417     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-12     Document Type: Article

References (46)

1. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. Xu Y, AuCoin DP, Huete AR, Cei SA, Hanson LJ, Pari GS, J Virol 2005 79 3479 3487 10.1128/JVI.79.6.3479-3487.2005 15731242 (Pubitemid 40327936)
2. Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression. Sakakibara S, Ueda K, Chen J, Okuno T, Yamanishi K, J Virol 2001 75 6894 6900 10.1128/JVI.75.15.6894-6900.2001 11435569 (Pubitemid 32641576)
3. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D, Genes Dev 2002 16 1977 1989 10.1101/gad.996502 12154127 (Pubitemid 34832925)
4. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. Wang SE, Wu FY, Yu Y, Hayward GS, J Virol 2003 77 9590 9612 10.1128/JVI.77.17.9590-9612.2003 12915572 (Pubitemid 37011053)
5. Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Gwack Y, Nakamura H, Lee SH, Souvlis J, Yustein JT, Gygi S, Kung HJ, Jung JU, Mol Cell Biol 2003 23 8282 8294 10.1128/MCB.23.22.8282-8294.2003 14585985 (Pubitemid 37377517)
6. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus. Yang Z, Wood C, J Virol 2007 81 6294 6306 10.1128/JVI.02648-06 17409159 (Pubitemid 46878036)
7. Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus. He Z, Liu Y, Liang D, Wang Z, Robertson ES, Lan K, J Virol 2010 84 2047 2062 10.1128/JVI.01984-09 19939918
8. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. Torres CR, Hart GW, J Biol Chem 1984 259 3308 3317 6421821 (Pubitemid 14130544)
9. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Hart GW, Housley MP, Slawson C, Nature 2007 446 1017 1022 10.1038/nature05815 17460662 (Pubitemid 46676063)
10. O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks. Slawson C, Housley MP, Hart GW, J Cell Biochem 2006 97 71 83 10.1002/jcb.20676 16237703 (Pubitemid 43050180)
11. O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. Wells L, Kreppel LK, Comer FI, Wadzinski BE, Hart GW, J Biol Chem 2004 279 38466 38470 10.1074/jbc.M406481200 15247246 (Pubitemid 39295998)
12. Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Wang Z, Gucek M, Hart GW, Proc Natl Acad Sci USA 2008 105 13793 13798 10.1073/pnas.0806216105 18779572
13. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Yang X, Zhang F, Kudlow JE, Cell 2002 110 69 80 10.1016/S0092-8674(02)00810-3 12150998 (Pubitemid 34874607)
14. Essential role of the glycosyltransferase sxc/Ogt in polycomb repression. Gambetta MC, Oktaba K, Muller J, Science 2009 325 93 96 10.1126/science.1169727 19478141
15. Drosophila O-GlcNAc transferase (OGT) is encoded by the Polycomb group (PcG) gene, super sex combs (sxc). Sinclair DA, Syrzycka M, Macauley MS, Rastgardani T, Komljenovic I, Vocadlo DJ, Brock HW, Honda BM, Proc Natl Acad Sci USA 2009 106 13427 13432 10.1073/pnas.0904638106 19666537
16. Polycomb repressive complex 2 is necessary for the normal site-specific O-GlcNAc distribution in mouse embryonic stem cells. Myers SA, Panning B, Burlingame AL, Proc Natl Acad Sci USA 2011 108 9490 9495 10.1073/pnas.1019289108 21606357
17. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Krishnakumar R, Kraus WL, Mol Cell 2010 39 8 24 10.1016/j.molcel.2010.06.017 20603072
18. PARP inhibition: PARP1 and beyond. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG, Nat Rev Cancer 2010 10 293 301 10.1038/nrc2812 20200537
19. Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. Ohsaki E, Ueda K, Sakakibara S, Do E, Yada K, Yamanishi K, J Virol 2004 78 9936 9946 10.1128/JVI.78.18.9936-9946.2004 15331727 (Pubitemid 39187112)
20. Ser-634 and Ser-636 of Kaposi's sarcoma-associated herpesvirus RTA are involved in transactivation and are potential CDK9 phosphorylation sites. Tsai WH, Wang PW, Lin SY, Wu IL, Ko YC, Chen YL, Li M, Lin SF, Front Microbiol 2012
21. Epstein-Barr Virus (EBV) Rta-Mediated EBV and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivations in 293 Cells. Chen YJ, Tsai WH, Chen YL, Ko YC, Chou SP, Chen JY, Lin SF, PLoS ONE 2011 6 17809 10.1371/journal.pone.0017809 21423768
22. A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription. Barlev NA, Emelyanov AV, Castagnino P, Zegerman P, Bannister AJ, Sepulveda MA, Robert F, Tora L, Kouzarides T, Birshtein BK, Berger SL, Mol Cell Biol 2003 23 6944 6957 10.1128/MCB.23.19.6944-6957.2003 12972612 (Pubitemid 37214662)
23. Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. Trester-Zedlitz M, Burlingame A, Kobilka B, von Zastrow M, Biochemistry (Mosc) 2005 44 6133 6143 10.1021/bi0475469 (Pubitemid 40570706)
24. Precise mapping of increased sialylation pattern and the expression of acute phase proteins accompanying murine tumor progression in BALB/c mouse by integrated sera proteomics and glycomics. Lin SY, Chen YY, Fan YY, Lin CW, Chen ST, Wang AH, Khoo KH, J Proteome Res 2008 7 3293 3303 10.1021/pr800093b 18549263
25. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. Lukac DM, Kirshner JR, Ganem D, J Virol 1999 73 9348 9361 10516043 (Pubitemid 29487090)
26. Detection and characterization of methionine oxidation in peptides by collision-induced dissociation and electron capture dissociation. Guan Z, Yates NA, Bakhtiar R, J Am Soc Mass Spectrom 2003 14 605 613 10.1016/S1044-0305(03) 00201-0 12781462 (Pubitemid 36870969)
27. Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements. Chang PJ, Shedd D, Gradoville L, Cho MS, Chen LW, Chang J, Miller G, J Virol 2002 76 3168 3178 10.1128/JVI.76.7.3168-3178.2002 11884541 (Pubitemid 34224518)
28. Down-regulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic, 2-deoxyglucose. Kang HT, Ju JW, Cho JW, Hwang ES, J Biol Chem 2003 278 51223 51231 10.1074/jbc.M307332200 14532290 (Pubitemid 38020359)
29. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Roos MD, Su K, Baker JR, Kudlow JE, Mol Cell Biol 1997 17 6472 6480 9343410 (Pubitemid 27451193)
30. O-linked N-acetylglucosamine modification on CCAAT enhancer-binding protein beta: role during adipocyte differentiation. Li X, Molina H, Huang H, Zhang YY, Liu M, Qian SW, Slawson C, Dias WB, Pandey A, Hart GW, Lane MD, Tang QQ, J Biol Chem 2009 284 19248 19254 10.1074/jbc.M109.005678 19478079
31. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Vieira J, O'Hearn PM, Virology 2004 325 225 240 10.1016/j.virol.2004.03.049 15246263 (Pubitemid 38902789)
32. Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Kraus WL, Curr Opin Cell Biol 2008 20 294 302 10.1016/j.ceb.2008.03.006 18450439
33. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K, Cell 2009 138 1019 1031 10.1016/j.cell.2009.06.049 19698979
34. CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50. Gwack Y, Byun H, Hwang S, Lim C, Choe J, J Virol 2001 75 1909 1917 10.1128/JVI.75.4.1909-1917.2001 11160690 (Pubitemid 32110181)
35. Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. Deng H, Young A, Sun R, J Gen Virol 2000 81 3043 3048 11086135 (Pubitemid 32000651)
36. Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Delgado T, Carroll PA, Punjabi AS, Margineantu D, Hockenbery DM, Lagunoff M, Proc Natl Acad Sci USA 2010 107 10696 10701 10.1073/pnas.1004882107 20498071
37. Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides. Chalkley RJ, Thalhammer A, Schoepfer R, Burlingame AL, Proc Natl Acad Sci USA 2009 106 8894 8899 10.1073/pnas.0900288106 19458039
38. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. Khidekel N, Ficarro SB, Clark PM, Bryan MC, Swaney DL, Rexach JE, Sun YE, Coon JJ, Peters EC, Hsieh-Wilson LC, Nat Chem Biol 2007 3 339 348 17496889 (Pubitemid 46789268)
39. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Yang X, Su K, Roos MD, Chang Q, Paterson AJ, Kudlow JE, Proc Natl Acad Sci USA 2001 98 6611 6616 10.1073/pnas.111099998 11371615 (Pubitemid 32538264)
40. O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter. Jochmann R, Thurau M, Jung S, Hofmann C, Naschberger E, Kremmer E, Harrer T, Miller M, Schaft N, Sturzl M, J Virol 2009 83 3704 3718 10.1128/JVI.01384-08 19193796
41. Cellular content of UDP-N-Acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-GlcNAc modification of transcription factors YY1 and SP1. Jokela TA, Makkonen KM, Oikari S, Karna R, Koli E, Hart GW, Tammi RH, Carlberg C, Tammi MI, J Biol Chem 2011 286 33632 33640 10.1074/jbc.M111. 265637 21795679
42. O-GlcNAc Modification of NFkappaB p65 Inhibits TNF-alpha-Induced Inflammatory Mediator Expression in Rat Aortic Smooth Muscle Cells. Xing D, Gong K, Feng W, Nozell SE, Chen YF, Chatham JC, Oparil S, PLoS ONE 2011 6 24021 10.1371/journal.pone.0024021 21904602
43. GlcNAcylation of histone H2B facilitates its monoubiquitination. Fujiki R, Hashiba W, Sekine H, Yokoyama A, Chikanishi T, Ito S, Imai Y, Kim J, He HH, Igarashi K, Kanno J, Ohtake F, Kitagawa H, Roeder RG, Brown M, Kato S, Nature 2011 480 557 560 22121020
44. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Sakabe K, Wang Z, Hart GW, Proc Natl Acad Sci USA 2010 107 19915 19920 10.1073/pnas.1009023107 21045127
45. Prediction of glycosylation across the human proteome and the correlation to protein function. Gupta R, Brunak S, Pac Symp Biocomput 2002 310 22
46. Predicting O-glycosylation sites in mammalian proteins by using SVMs. Li S, Liu B, Zeng R, Cai Y, Li Y, Comput Biol Chem 2006 30 203 208 10.1016/j.compbiolchem.2006.02.002 16731044 (Pubitemid 43783164)